Research hot spots and trends in endocrine-related adverse events caused by immune checkpoint inhibitors: a bibliometric analysis and visualization research

被引:0
|
作者
Zhao, Jun [1 ]
Liu, Guangwei [2 ]
Yang, Xue [1 ]
Zhang, Chuanzhou [1 ]
Han, Bing [1 ]
Jiang, Man [1 ]
机构
[1] Qingdao Univ, Dept Pharm, Affiliated Hosp, Qingdao, Shandong, Peoples R China
[2] Qingdao Univ, Dept Gastrointestinal Surg, Affiliated Hosp, Qingdao, Shandong, Peoples R China
来源
关键词
immune checkpoint inhibitor; endocrine; adverse events; toxicity; bibliometrics; visual analysis; NIVOLUMAB PLUS IPILIMUMAB;
D O I
10.3389/fendo.2024.1253832
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background In recent years, with the widespread use of immune checkpoint inhibitors (ICIs) in cancer treatment, the toxicity associated with immunotherapy of ICIs has attracted more attention from scholars. Endocrine toxicity is the most likely immune-related adverse events (irAEs) and is often irreversible, posing a significant clinical treatment challenge.Methods In this study, bibliometric methods were used to analyze relevant literature in screening endocrine-related adverse events caused by ICIs in the Web of Science core collection database (WoSCC) and to summarize the status, research hot spots, and future trends in this field.Results 321 countries, 297 institutions, 365 authors, and 305 journals had published 671 English documents on endocrine adverse reactions of ICIs as of 1 December, 2022. The United States, Japan, and China were the top three countries with the most publications. The University of Texas MD Anderson Cancer Center, Harvard Medical School, and Memorial Sloan Kettering Cancer Center were the top three research institutions in terms of publication output. F Stephen Hodi, from the Dana-Farber Cancer Institute in the United States, contributed the largest number of publications. Frontiers in Oncology, which was the most widely distributed publication in the field. The main keywords or clusters identified that current research hotspots include the management of endocrine-related adverse events, hypophysitis, thyroid dysfunction, type I diabetes mellitus, and the impact of endocrine adverse events on survival of patients in this field.Conclusion The basic knowledge structure of the field of endocrine-related adverse events of ICIs, including publication trends, authors, institutions, countries, keywords, journals and publications, and cited documents, was visually analyzed in this bibliometric analysis. The research results comprehensively demonstrated the hot spots and future trends in the research field, as well as its broad prospects, thus providing a reference for the researchers.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] Endocrine-Related Adverse Events Related to Immune Checkpoint Inhibitors: Proposed Algorithms for Management
    Del Rivero, Jaydira
    Cordes, Lisa M.
    Klubo-Gwiezdzinska, Joanna
    Madan, Ravi A.
    Nieman, Lynnette K.
    Gulley, James L.
    [J]. ONCOLOGIST, 2020, 25 (04): : 290 - 300
  • [2] Endocrine-related adverse events associated with immune-checkpoint inhibitors in patients with melanoma
    Kassi, Eva
    Angelousi, Anna
    Asonitis, Nikolaos
    Diamantopoulos, Panagiotis
    Anastasopoulou, Amalia
    Papaxoinis, George
    Kokkinos, Michalis
    Giovanopoulos, Ilias
    Kyriakakis, Georgios
    Petychaki, Fotini
    Savelli, Akrivi
    Benopoulou, Olga
    Gogas, Helen
    [J]. CANCER MEDICINE, 2019, 8 (15): : 6585 - 6594
  • [3] A Systematic Review and Meta-Analysis of Endocrine-Related Adverse Events Associated with Immune Checkpoint Inhibitors
    de Filette, Jeroen
    Andreescu, Corina Emilia
    Cools, Filip
    Bravenboer, Bert
    Velkeniers, Brigitte
    [J]. HORMONE AND METABOLIC RESEARCH, 2019, 51 (03) : 145 - 156
  • [4] Research Trends in Immune Checkpoint Blockade for Melanoma: Visualization and Bibliometric Analysis
    Xu, Yantao
    Jiang, Zixi
    Kuang, Xinwei
    Chen, Xiang
    Liu, Hong
    [J]. JOURNAL OF MEDICAL INTERNET RESEARCH, 2022, 24 (06)
  • [5] Bibliometric analysis of rheumatic immune related adverse events associated with immune checkpoint inhibitors
    Zeng, Li
    Ma, Gang
    Chen, Kai
    Zhou, Qiao
    [J]. FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [6] New insight in endocrine-related adverse events associated to immune checkpoint blockade
    Elia, Giusy
    Ferrari, Silvia Martina
    Galdiero, Maria Rosaria
    Ragusa, Francesca
    Paparo, Sabrina Rosaria
    Ruffilli, Ilaria
    Varricchi, Gilda
    Fallahi, Poupak
    Antonelli, Alessandro
    [J]. BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2020, 34 (01)
  • [7] Endocrine-related adverse events associated with immune checkpoint blockade and expert insights on their management
    Sznol, Mario
    Postow, Michael A.
    Davies, Marianne J.
    Pavlick, Anna C.
    Plimack, Elizabeth R.
    Shaheen, Montaser
    Veloski, Colleen
    Robert, Caroline
    [J]. CANCER TREATMENT REVIEWS, 2017, 58 : 70 - 76
  • [8] The biomarkers related to immune related adverse events caused by immune checkpoint inhibitors
    Xiao-Hui Jia
    Lu-Ying Geng
    Pan-Pan Jiang
    Hong Xu
    Ke-Jun Nan
    Yu Yao
    Li-Li Jiang
    Hong Sun
    Tian-Jie Qin
    Hui Guo
    [J]. Journal of Experimental & Clinical Cancer Research, 39
  • [9] The biomarkers related to immune related adverse events caused by immune checkpoint inhibitors
    Jia, Xiao-Hui
    Geng, Lu-Ying
    Jiang, Pan-Pan
    Xu, Hong
    Nan, Ke-Jun
    Yao, Yu
    Jiang, Li-Li
    Sun, Hong
    Qin, Tian-Jie
    Guo, Hui
    [J]. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2020, 39 (01)
  • [10] Endocrine adverse events of immune checkpoint inhibitors
    Merlen, E.
    [J]. CORRESPONDANCES EN METABOLISMES HORMONES DIABETES ET NUTRITION, 2023, 27 (4-5): : 128 - 131